Document Detail

Hypocomplementemia in multiple myeloma.
MedLine Citation:
PMID:  10221517     Owner:  NLM     Status:  MEDLINE    
We report the results of a prospective study of the complement system in a cohort of 22 multiple myeloma patients: 11 women and 11 men, median age 66 years. There were 10 IgG, 8 IgA, 2 IgM and 2 light chain myeloma patients. Seven were in stage 1, 3 in stage 2 and 12 in stage 3. The serum complement component levels of the three pathways were measured in all patients and compared to normal values of 29 healthy controls. We found a depleted common pathway in 21 patients, and deficient alternative and terminal pathways in 6 patients. There was no difference in the complement profile of myeloma patients in the advanced or early stages of the disease. IgG and IgA myeloma patients had a similar complement profile. Nine patients, 7 with advanced disease, developed 17 infectious episodes. Most of these patients had a deficient classical pathway, but normal alternative and terminal pathways. This profile was not different from the complement system observed in patients without infectious complications. Activation of the three pathways of the complement system was evaluated in all 22 patients. The classical and alternative pathways were activated in most patients in early and late stages, but the terminal pathway (C5-C9) was more frequently activated in the later stages (7 of 12 patients) that in the earlier stages (1 of 10). We conclude that the complement system is deficient in multiple myeloma, most probably because of activation of the system, although no correlation could be demonstrated between the complement system and the clinical manifestations of the disease.
G Lugassy; I Platok; M Schlesinger
Related Documents :
3389587 - The response of immunoglobulins to infection after thermal and nonthermal injury.
25171447 - Severe hemolytic transfusion reaction due to anti-d in a d+ patient with sickle cell di...
10720117 - Reliance on serum endomysial antibody testing underestimates the true prevalence of coe...
170707 - The hl-a and abo antigens in trophoblastic disease.
19289757 - Necrobiotic xanthogranuloma: a review of 17 cases with emphasis on clinical and patholo...
17101367 - Portal vein thrombosis after splenectomy in pediatric hematologic disease: risk factors...
Publication Detail:
Type:  Comparative Study; Journal Article    
Journal Detail:
Title:  Leukemia & lymphoma     Volume:  33     ISSN:  1042-8194     ISO Abbreviation:  Leuk. Lymphoma     Publication Date:  1999 Apr 
Date Detail:
Created Date:  1999-06-10     Completed Date:  1999-06-10     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  9007422     Medline TA:  Leuk Lymphoma     Country:  SWITZERLAND    
Other Details:
Languages:  eng     Pagination:  365-70     Citation Subset:  IM    
Institute of Hematology, Barzilai Medical Center, Ashkelon, Israel.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Aged, 80 and over
Bacterial Infections / etiology
Candidiasis / etiology
Complement Activation
Complement System Proteins / metabolism*
Immunoglobulin A / immunology
Immunoglobulin G / immunology
Immunoglobulin Light Chains / immunology
Immunoglobulin M / immunology
Middle Aged
Multiple Myeloma / blood*,  complications,  immunology*
Prospective Studies
Reference Values
Virus Diseases / etiology
Reg. No./Substance:
0/Immunoglobulin A; 0/Immunoglobulin G; 0/Immunoglobulin Light Chains; 0/Immunoglobulin M; 9007-36-7/Complement System Proteins

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Changes of hemostatic factors in children with acute lymphoblastic leukemia receiving combined chemo...
Next Document:  Expression of receptor tyrosine kinase HTK (hepatoma transmembrane kinase) and HTK ligand by human l...